NT-proBNP May Predict Cardiovascular Outcomes in Type 2 Diabetes
Changes in N-terminal B-type natriuretic peptide levels from baseline and 6 months were associated with adverse outcomes.
All articles by Sunali Wadehra, MD
Outcomes of Treatment Strategies in T2D, Stable CAD According to Angina Severity
Investigators demonstrated that angina severity at baseline should be a less important aspect of the diagnostic and therapeutic algorithm.
Continuous Subcutaneous Insulin Infusion May Reduce Basal Hyperglycemia in T2D
Patients with type 2 diabetes who were initially treated with multiple daily injections were assessed before and after switching to continuous subcutaneous insulin infusion.
HbA1c Variability Predicts All-Cause Mortality in Type 2 Diabetes
HbA1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes and appears to be more powerful than average HbA1c in predicting all-cause death.
Autism Does Not Affect Metabolic Control in Type 1 Diabetes
Awareness of ASD and its manifestations and comorbidities remain imperative in the treatment of T1D, as both conditions require long-term medical follow-up to continue improving diabetes care and metabolic control outcomes.
Next post in Type 1 Diabetes
